Abstract-Droplet-based digital microfluidics technology has now come of age, and software-controlled biochips for healthcare applications are starting to emerge. However, today's digital microfluidic biochips suffer from the drawback that there is no feedback to the control software from the underlying hardware platform. Due to the lack of precision inherent in biochemical experiments, errors are likely during droplet manipulation; error recovery based on the repetition of experiments leads to wastage of expensive reagents and hard-to-prepare samples. By exploiting recent advances in the integration of optical detectors (sensors) into a digital microfluidics biochip, we present a physicalaware system reconfiguration technique that uses sensor data at intermediate checkpoints to dynamically reconfigure the biochip. A cyberphysical resynthesis technique is used to recompute electrode-actuation sequences, thereby deriving new schedules, module placement, and droplet routing pathways, with minimum impact on the time-to-response.
number of techniques have been published for architecturallevel synthesis [3] , module placement, and droplet routing [4] [5] [6] . However, these techniques ignore domain-specific constraints or practical realities that arise from attempting to carry out biochemical reactions and microfluidic operations on an electronic chip. Due to the randomness and complex component interactions that are ubiquitous in biological or chemical processes, predictive modeling and accuracy control are difficult [7] , [8] . In addition to manufacturing defects and imperfections, faults may also arise during bioassay execution. For example, excessive actuation voltage applied to an electrode may lead to breakdown of electrodes and charge trapping, and DNA fouling may lead to malfunction of multiple electrodes in the biochip [9] [10] [11] . These faults are hard to detect a priori, but they occur often during bioassays [11] . Yet, despite such inherent variability, many biomedical applications such as drug development and clinical diagnostics require high precision for each operation and correctness of the final result under various conditions. If an unexpected error occurs during the experiment, the outcome of the entire experiment will be incorrect. As a result, all the steps in the experiment must be repeated in order to correct the error [12] .
The repetitive execution of on-chip laboratory experiments leads to the following problems: 1) wastage of samples that are difficult to obtain or prepare, 2) wastage of expensive reagents, and 3) increase in the time-to-result for a bioassay, which is detrimental to real-time detection and rapid response. Therefore, it is necessary to develop techniques for monitoring assay outcomes at intermediate stages and design an efficient error-recovery mechanism.
Error recovery in digital microfluidics has received relatively little attention in the literature. The only reported work is [13] , which proposed intermediate stage monitoring and rollback error-recovery for a microfluidic biochip. The key idea in this paper is to use optical sensors to verify the correctness of immediate product droplets at various steps in the on-chip experiment. Optical detection has been integrated with digital microfluidics to evaluate the concentration and volume of product droplets [2] , [14] , [15] . In the recent approach described in [13] , error recovery is carried out as follows. During bioassay execution, intermediate product droplets are sent to optical sensors. When an error is detected at an optical sensor, i.e., the volume or concentration of the droplet is below or above the acceptable calibrated range, the corresponding droplet is discarded. The operations whose outputs fail to meet the quality requirements based on sensor 0278-0070/$31.00 c 2012 IEEE calibration are re-executed to generate a new product droplet to replace the unqualified droplet. Fig. 1 shows an example of rollback error-recovery. The initial sequencing graph of a bioassay is shown in Fig. 1(a) . Here, we assume that the outputs of each dispensing, mixing and splitting operation are evaluated by an optical sensor. When an error occurs at operation 9, the system will re-execute the corresponding dispensing and mixing operations. The new sequencing graph for error recovery is shown in Fig. 1(b) . Operations 16, 17, 18 , and 19 are added for error recovery. The new sequencing graph for error recovery is shown in Fig. 1(b) . Operations 16, 17, 18 , and 19 are added for error recovery. It is important to note that the error is detected at operation 9, and thus it is unnecessary to continue executing the splitting operation after operation 9 anymore. Thus, node 12 is removed from Fig. 1(b) .
In the absence of physical-aware control software, the error recovery method in [13] suffers from following drawbacks.
1) The first drawback is the oversimplification of fault detection and the associated assumptions. Using a uniform expected value for the calibration of each optical detection operation is not practical. Note that at various stages during bioassay execution, the concentration of intermediate product droplets varies in a dynamic manner; hence, the calibration also needs to be repeated and carried out dynamically. 2) In [13] , all recovery operations are carried out in a stand-alone manner. When an error is detected, all other ongoing bioassay-related fluidic operations are interrupted. The potentially long waiting times introduced by recovery operations can lead to sample degradation and erroneous assay outcomes [16] . Some operations, such as colorimetric enzyme-kinetic reactions, require precise durations as specified by the reaction protocol, and they cannot be extended without introducing unpredictability in the experiment outcome [15] . 3) The error recovery approach in [13] cannot handle situations when multiple errors occur during a bioassay. For example, it assumes that all error recovery operations will be executed successfully and it does not consider the likelihood that errors can also occur during recovery. 4) The error recovery strategy in [13] does not consider reliability issues. Errors such as the generation of droplets with abnormal volumes are usually caused by the accumulation of charge on the surface of certain electrodes [9] , [10] . If the use of such electrodes is continued, it is likely that they will introduce more errors [9] , [10] . Thus, in order to ensure the reliability of biochips, we must minimize the utilization of these electrodes.
To overcome the above drawbacks, we take a transformative cyberphysical approach toward achieving closed-loop and sensor feedback-driven biochip operation under program control. By exploiting recent advances in the integration of optical detectors (sensors) in a digital microfluidics biochip [14] , we present a physical-aware system reconfiguration technique that uses sensor data at intermediate checkpoints to dynamically reconfigure the biochip [17] . The key contributions of this paper are as follows. 1) Charge-coupled device (CCD)-based and optical detector-based sensing systems for digital microfluidic biochip are proposed and compared (Section II). 2) An algorithm is proposed for the measurement and tracking of droplets based on real-time imaging data from a CCD camera (Section II). 3) A reliability-driven error recovery strategy is proposed (Section III). 4) Parallel recombinative simulated annealing (PRSA)-based and greedy algorithms for reliability-driven synthesis are presented (Section IV). 5) Simulation results are presented for three representative bioassays (Section V).
II. Overview of Digital Microfluidic Biochips and
Cyberphysical System A digital microfluidic system includes a microfluidic biochip and control software. A digital microfluidic biochip consists of three types of components: a 2-D electrode array, on-chip reservoirs, and sensors [18] . By utilizing the principle of electrowetting, picoliter droplets containing biological or chemical samples and reagents can be manipulated on the chip without any curved channels or external pressure sources [2] , [19] . Fig. 2 shows the structure of an element cell on a microfluidic biochip [2] . The upper plate is a large electrode that covers all cells on the array and serves as the ground electrode for all unit cells [2] , [18] . The lower plate of the unit cell consists of an array of discrete control electrodes. During biochip operation, the unit cells in the array may have different voltages applied on their lower electrodes [2] , [18] . The movements of droplets are determined by signals applied on the discrete lower electrodes of the array.
As seen in Fig. 2 , droplets manipulated by the digital microfluidic biochip are confined between the upper and lower electrodes [2] . To move a droplet, a high voltage must be applied to a unit cell adjacent to the droplet, and, at the same time, a low voltage must be applied to the cell under the droplet [2] . The voltages applied on the electrodes can influence the surface characteristics of the hydrophobic material on the lower electrodes. In this way, the different voltages applied on the electrodes result in different levels of interfacial tension on the surface of the biochip [2] . Due to this effect, the droplet is moved from the low-voltage electrode to the high-voltage electrode [2] . All the microfluidic functions, such as droplet merging, splitting, mixing, and dispensing, can be reduced to a set of basic operations [18] . Concurrent manipulation of multiple discrete droplets can be coordinated by control software and by voltages applied to the electrodes, so there is no need for mechanical devices, such as tubes, pumps, and valves [19] .
With the availability of sensing systems for biochips, physical-aware control software becomes feasible. By physical-aware, we refer to the fact that the software can receive information about the outcome (error-free or erroneous) of fluid-handling operations based on feedback from the sensing system. Depending on sensor feedback, the control software can appropriately reconfigure the microfluidic biochip. In this way, the various steps in the bioassay are executed based upon real-time sensing of intermediate results. Fig. 3 depicts each component of a cyberphysical system on the microfluidic platform. The control software sends a control signal to the microfluidic biochip, and the on-chip sensing system monitors the outcomes of fluidic operations. The outcomes are compared with the expected values, i.e., the predetermined thresholds. If the results of the comparison indicate that an error has occurred, the control software receives a repeat request, and the corresponding operation in which the error occurred can be executed again, thereby correcting the error.
A. Sensing Systems
Two sensing schemes can potentially be used in the cyberphysical system on digital microfluidic biochips.
The first sensing scheme is CCD camera-based. As described in [2] and [20] , CCD cameras can be used in experiments to view the top sides of droplets simultaneously. An example of the CCD monitoring system is shown in Fig. 4 .
Based on the images captured by the CCD camera, droplets can be automatically located by the control software. The procedure of automatically searching for droplets can be described as a template matching problem. Here, a pattern can be represented as the image of a typical droplet. During the matching process, we move the template image to all possible positions in the image of the entire array and crop a subimage that has the same size as the template image. Then, the control software computes the correlation index, which indicates the similarity between the template and the cropped image. This process is shown in Fig. 5 (a) and the correlation factor is calculated on a pixel-by-pixel basis.
In the control software, all images are stored in a grayscale form, which can be encoded as matrices or vectors. Suppose the template image is represented in a 1-D array: x = (x 1 , x 2 , ..., x N ). Here, x i represents the gravel level of a pixel and N is the total number of pixels in the template image. Similarly, the cropped subimage to be compared with the template image can be written as y = (y 1 , y 2 , ..., y N ). Thus, the correlation factor between these two images is defined as follows:
wherex andȳ are the average gray level in the template image and cropped subimage, respectively. The range of correlation factor cor is a real number between −1 and +1. According to the definition of correlation, a larger value represents a stronger relationship between two images. After deriving the correlation factors for all possible positions in the image for the complete biochip, we obtain the correlation map between the template and the original input image. Suppose there are κ droplets on the biochip. By searching for the largest κ correlation factors in the correlation map, the locations of droplets can be determined. An example is shown in Fig. 5(b) and (c) [21] . Part (b) shows the original input image of the whole chip and the pattern image, and (c) is the correlation map, where the best matching locations, i.e., the coordinations of droplets derived by the control software are (77, 107), (77, 147), and (76, 208). Thus, the control software automatically locates the droplets, and it can further analyze the sizes and colors of droplets according to the image. In this manner, the volumes and concentrations of droplets can be acquired after processing the image taken by the CCD camera. Instead of searching for droplets in the complete image, we use imaging to check whether the droplets have been moved to the expected positions. This is implemented using the following steps.
First, we do some calibration before the experiment. We choose a large number of subimages with (or without) droplets, and calculate their correlation with the template. Based on this calculation, we find an appropriate threshold for the correlation index (C th ): if the correlation is larger than C th , we conclude that there is a droplet in the cropped subimage; otherwise, there is no droplet in the subimage. When the bioassay is running, we only need to crop the subimages near the expected positions of droplets, and calculate their corresponding correlation indices to determine the absence or presence of droplets.
The advantages of the CCD camera-based sensing system are: 1) the detection of errors immediately after they occur, and 2) the identification of the precise locations of the errors. A disadvantage of this system is that extra instruments, such as CCD cameras, are required to observe the cyberphysical system.
The second sensing scheme is based on integrated optical detectors, as proposed in [14] and [15] . The quality of an intermediate product in a digital microfluidic biochip can be determined by examining the concentration of the product in the droplets through fluorescence [14] , [15] . When a fluorophore tag is attached to a droplet, different product concentrations lead to the emission of different light wavelengths (i.e., different colors). This difference in color can be detected by optical sensors that convert the received light into electrical current or a voltage signal [14] . In recent work, integrated photodetectors have been introduced on the microfluidic array [14] , [15] . For example, in [15] , an optical detection system was integrated with the digital microfluidic array. It consists of a light-emitting diode and a photodiode which functions as a light-to-voltage converter. The concentration of products on the array can be measured by the absorbance of the droplets using a kinetic rate method. As another example, thin film InGaAs photodetectors can be bonded onto a glass platform, coated with Teflon AF, and then integrated into the digital microfluidic system.
Even though no instruments with large footprint and precise alignment are needed in this method, the integrated optical detector-based sensing system has a drawback that it cannot precisely locate the electrode where an error has occurred. For example, when an output droplet of an operation is sent to the detector and it fails to meet the requirement of the bioassay, we know that an error occurred during the mixing operation, but we cannot locate the precise time and the position where it occurred.
B. Physical-Aware Software
The availability of on-chip sensors provides digital microfluidic biochips with the capability of using sensor data at intermediate checkpoints to detect errors, thereby minimizing the impact of errors that occur during bioassay execution. The work in [13] proposed intermediate stage monitoring and rollback error-recovery for a microfluidic biochip. The key idea in this paper is using the sensing system-on-chip to verify the correctness of output droplets at various steps in the onchip experiment. In this approach, error recovery is carried out as follows. When an error is detected at a checkpoint, operations whose outputs failed to meet the quality requirements based on sensor calibration are re-executed to recover from the error. Additional intermediate product droplets must be stored in specially designated locations of the chips to facilitate recovery. Additional droplets of samples and reagents must also be dispensed from reservoirs for error recovery. The details of the strategy for reliability-driven error recovery are presented in Section III, and the algorithm for dynamic resynthesis of error recovery is described in Section IV.
C. Interfaces Between Biochip and Control Software
We next describe the cyberphysical coupling between the control software and the hardware of the microfluidic platform. There are two interfaces needed for cyberphysical coupling. The first interface converts the output signals from the sensing system to the inputs of the desktop computer that the control software can interpret. The second interface converts the output data generated by the control software to voltage signals that can be directly applied to the electrodes of the biochip.
As described in [3] , biochip synthesis includes resource binding and scheduling, which specifies the start and stop times of fluidic operations. The synthesis results (control software) need to be mapped to a sequence of electrode actuation vectors consisting of "0," "1," and "F" (floating). A programmable logic controller (PLC) is used as the interface between the output of the control software (controller) and the control pins of the biochip.
During bioassay execution, the PLC reads the electrode actuation sequences stored in memory and applies the appropriate sequence of voltages to the output pins. When the PLC generates output voltages based on sequences in its memory, corresponding activation voltages are applied to the electrodes of the biochip. The quality of an intermediate product in a digital microfluidic biochip can be determined by examining the product concentration in droplets through fluorescence [22] , [23] . When a fluorophore tag is attached to a droplet, different product concentrations lead to emitted light of different wavelengths (i.e., different colors). This difference in color can be detected by the sensing system that converts the received analog signals into electrical current or voltage [2] . Recent advances in the integration of a multiplicity of such miniaturized sensors provide an important motivation for the cyberphysical hardware or software codesign approach studied in this paper.
III. Reliability-Driven Error Recovery Strategy

A. Error Recovery Strategies
In this subsection, we formulate the principles underlying error recovery. For the given bioassay protocol, we use the sensing system-on-chip to evaluate the quality of output droplets of each dispensing, mixing, dilution and splitting operation. According to the data provided by [2] , the response times of on-chip optical sensors are in the scale of picoseconds or nanoseconds. Thus, the time cost for adding optical detection operations is negligible.
For a microfluidic biochip, fluid-handling operations can be divided into two categories: reversible and nonreversible operations. Reversible operations include dispensing and splitting operations; nonreversible operations include mixing and dilution operations. For errors that occur at reversible operations, their recovery processes are relatively simple. In a splitting operation, if two droplets with unbalanced volumes are generated, then the biochip will first merge the two abnormal droplets to a larger one and then split the larger droplet again. For errors that occur at a dispensing operation, the chip can send the abnormal droplet back to the corresponding reservoir and dispense another droplet. Thus for errors that occur at reversible operations, the time cost for recovery is small and no additional droplets need to be consumed.
The error recovery process for nonreversible operations is more involved. To implement the corresponding nonreversible operations to correct the error, we also need input droplets from operations whose outputs feed the inputs of the failed operation. Thus, we may need to re-execute all the predecessors of the erroneous operation. For instance, if an error occurs at operation 7 in Fig. 6(a), operations 1, 2, 3, 4 , 5, and 6 may need to be re-executed. Thus, the time cost for executing error recovery operations can be extremely high. To reduce the incidence of the worst case, the following strategies are taken in our approach.
1) For a splitting operation, if only one of its output droplets is used as the input for the immediate successors, we store the other (redundant) droplet as a backup for possible error recovery at a subsequent stage. For example, operation 7 in Fig. 6(a) is a splitting operation and it generates two output droplets. Only one of these two droplets is used as the input of operation 9. (Note here each circle in the sequencing graph stands for a fluid-handling operation. The unused droplets are not shown in the sequencing graph.) If an error occurs at operation 9, the redundant droplet will be used as an input for re-execution. 2) All dispensing operations are scheduled for execution as early as possible and their output droplets are stored on the biochip. We also dispense some droplets as backup for possible error recovery operations. When the bioassay is completed, those unused backup droplets are sent back to the corresponding reservoirs.
Thus, when an error occurs at a nonreversible operation, the control software first checks whether the inputs of this operation can be provided by backup droplets stored on chip. If the answer is yes, then the time cost for this operation can be reduced. Otherwise, more operations will be executed during error recovery. Based on the above discussion, the operations in the sequencing graph can be divided into three categories according to the number of operations and droplet consumptions in their error recovery processes, as shown in Fig. 6(a) .
The above operations can be formally categorized as follows.
Category I: this is the set of all reversible operations. They can be simply re-executed when an error occurs.
Category II: this is the set of nonreversible operations for which immediate predecessors can provide backup droplets.
Category III: this corresponds to the set of nonreversible operations for which their immediate predecessors cannot provide backup droplets.
In a given sequencing graph, each node represents an operation. We define the number of input droplets as the innumber of an operation, and the number of output droplets as the out-number of an operation. As described below, any operation opt k can be categorized based on its in-number and out-number values. For an operation opt i , the set of its error recovery operations, R i , can be derived according to the categorization result for opt i . Operations in Categories I and II can be simply reexecuted when an error occurs because their input droplets are stored on chip. However, for operations in Category III, their inputs come from the outputs of predecessor operations and we do not have backup for these droplets. Thus if an error occurs in an operation of Category III, we not only need to re-execute the operation itself but also to backtrace to its predecessors. Suppose the error operation is opt e and its immediate predecessors are operations opt p 1 2 into R i . This backtracing and enlarging procedure needs to be repeated until we reach predecessor operations that can provide backup droplets to feed the inputs of operations in the set of error operations.
The above procedure of backtracing and enlarging the set R i can be described as follows. First, we define the mapping pred(opt i ) to be a mapping from opt i to the set of immediate predecessors of opt i in the sequencing graph.
For a set of operations
where P r is a backtracing operation. For any operation opt i , its set of error recovery operations R i can be derived by the procedure, as presented in Fig. 7 . According to the above discussion, we can derive the set of recovery operations R i for any operation opt i .
Based on the relationship between operations in the initial sequencing graph, we can further add edges between operations in the set R i , and thus derive the error recovery graph G Re i for opt i . If an error occurs in opt i , we will re-execute operations in G Re i for error recovery.
It is important to note that some electrodes on the biochip are intentionally left unused and reserved for storage of backup droplets. An example is shown in Fig. 6(b) ; all electrodes on the boundary of the chip are used as storage cells. Thus, backup droplets can easily be transported on the biochip.
B. Reliability Consideration in Recovery
When an error is detected during the execution of a bioassay, simply re-executing the operation for which an error occurred is not efficient to ensure reliable operation. This is because the errors that occur during the execution of a bioassay usually are caused by defects involving electrodes, thus, multiple errors may occur in the same region of the biochip at different times. Two examples are provided below to illustrate the errors caused by the charge-trapping phenomenon and DNA fouling.
When the electrodes of a digital microfluidic biochip are actuated excessively, physically trapped charge and residual charge may lead to reliability problems [9] , [10] . Charge trapping is a phenomenon in which charge is trapped and concentrated in the dielectric insulator of the chip. It can lead to a reduction in the electrowetting force and malfunctions in the execution of the bioassay. An example is shown in Fig. 8(a) . Suppose Electrode 1 has a trapped charge in its dielectric insulator layer, while Electrodes 2 and 3 do not suffer from charge sharing. In order to implement a splitting operation, high voltages are applied on Electrodes 1 and 3. However, the charge trapped on Electrode 1 will reduce the electrowetting force. The droplet will be split by unequal forces, and the two resulting droplets may have unequal volumes [see Fig. 8(b) ]. If we simply re-execute the splitting operation and continue to use Electrode 1, additional errors may result. Even worse, the charge-trapping phenomenon eventually may cause permanent dielectric degradation of the electrode [9] , [10] . Thus, once an error is detected, the electrode at which the error occurred must no longer be used to implement fluid-handling operations in order to ensure the reliability of the biochip.
When droplets contain macromolecules, such as DNA, they may foul the surface of the electrodes [24] . As a result, droplet concentration can change in undesirable ways. If we continue to use these contaminated electrodes, other droplets may also be contaminated. An example of this is shown in Fig. 8(c) . The region where DNA fouling occurred is used as part of Fig. 1(a) .
a mixer, and the concentrations of the output droplets of the mixing operation may be abnormal. We use a simple strategy to ensure a reliability-driven error recovery. When an error is detected, we update the execution of the bioassay as follows.
1) The operation with an error is re-executed.
2) The electrodes that may lead to errors will not be used in other operations. Note that for each operation, the on-chip resources occupied by it are all recorded by the control software. Thus depending on the error droplet, it is easy to backtrace to the region where an error occurs. We consider all electrodes in this region as the possible locations for defects. These electrodes will therefore be discarded.
C. Comparison Between Two Sensing Schemes
The two sensing schemes introduced in Section II have differences in the context of fault diagnosis, error recovery, and dynamic resynthesis.
The diagnosis of an electrode with trapped charge can be used to illustrate the difference between these two systems. Suppose a splitting operation with unbalanced droplets occurs, as shown in Fig. 8(b) . In the CCD camera-based sensing system, Electrode 1 can easily be identified as the electrode with residual charges because the droplet volume is smaller than the normal volume.
On the other hand, for the optical detector-based sensing system, the outputs of splitter, which consists of Electrodes 1, 2, and 3 shown in Fig. 8(b) , will no longer be used. In contrast to the diagnosis result of the CCD camera-based sensing system, Electrodes 2 and 3 can no longer be used, leading to wastage of on-chip resources. Here, we use the bioassay, as shown in Fig. 1 , to illustrate the differences of these two sensing schemes.
Suppose the droplets for dispensing operations 1-6 in Fig. 1(a) are generated from different dispensing ports. Table I shows the synthesis results for all mixing operations of the bioassay, as shown in Fig. 1(a) . The module placement result corresponding to the synthesis result in Table I is shown in Fig. 9 . It is important to note that in Table I resource refers to part of the electrode array occupied by the mixing operation. The location of a mixer is expressed in terms of the location of the electrode at the upper left corner of the mixer. For example, the upper left corner of the mixing module M 1 is in the sixth row and second column; it includes an electrode array with two rows and three columns. Thus, the mixer is described as a 3×2 mixer at the location (2, 6) .
Suppose that the DNA-fouling phenomenon occurs in the operation Mix 3 shown in Table I after the operation has been underway for 3 s. For the optical detector-based sensing system, the output of Mix 3 is checked only after Mix 3 has been completed. Thus, the error recovery process is triggered at time instant t = 10. For the CCD camera-based system, the error-recovery process will be triggered immediately after DNA fouling occurs at time instant t = 3. The synthesis results for these two cases are shown in Figs. 10 and 11 , respectively. We find that in the CCD camera-based sensing system, recovery can be triggered immediately after an error occurs. On the other hand, in a detector-based sensing system, recovery can only be triggered at the end of the erroneous operation.
Even though the CCD camera-based sensing system can precisely locate the position of electrodes with defects and trigger recovery immediately after an error occurs, light from the camera may influence some biochemical substances, e.g., fluorescent markers in the droplet [25] . Thus in order to monitor experiments that include photosensitive samples or reagents, we need to choose the detector-based sensing scheme.
IV. Error Recovery and Dynamic Resynthesis
With the availability of hardware that can send feedback to the control software, it is now necessary to design physicalaware software that can analyze sensor data and dynamically adapt to it. Adaptations include updates for the schedule of fluid-handling operations, resource binding, module placement, and droplet routing pathways.
The task of the control software includes two phases: the first phase is offline data preparation before the execution of bioassay and the second phase is online monitoring for the fluid-handling operations as well as dynamic resynthesis of the bioassay. Details are presented as follows.
A. Offline Data Preparation Before Bioassay Execution
The first step in data preparation is to convert the sequencing graph of the bioassay into a directed acyclic graph (DAG) and store it in memory for use by the control software. In this DAG, the vertices represent microfluidic handling operations and the edges represent precedence relations between operations. The predecessors and successors of any operation can be determined by performing depth-first search on the graph [26] .
The second step in data preparation is to assign error thresholds for each operation. These thresholds are determined by the requirement of precision for the bioassay and they are stored as a table in memory for use by the control software. During bioassay execution, if an optical detection result is outside the range of preassigned threshold values, we conclude that an error has occurred at the corresponding operation.
The last step in data preparation is the initial synthesis step for the bioassay. In this procedure, we map the sequencing graph of the bioassay and on-chip resources to the scheduling, resource binding, module placement, and droplet routing results for each operation.
For a sequencing graph consisting of n operations, the synthesis result can be written as the following set: (1), the x-coordinate of ith operation can be written as M * opt i (3) , and the number of columns occupied by opt i can be written as M * opt i (5) . For simplicity, we write the set of all operations in the bioassay as P, and we use C to refer to the set of constraints that S must satisfy, which include the following. 
which implies that operations opt w and opt v are implemented concurrently. It is important to note that multiple operations cannot share on-chip resources (including electrodes, dispensing ports, and detectors) at the same time. Thus, opt w and opt v must satisfy the following constraint: (2) . The completion time of the bioassay can be written as follows:
Thus, the synthesis of the biochip can be viewed as an optimization problem. The inputs are the set of operations P and the set of constraints C. The target is as follows:
minimize Max
Previously published CAD methods for digital microfluidic biochip have proposed several algorithms to solve this optimization problem. For example, the PRSA-based synthesis algorithms can be used to quickly derive optimized synthesis results [27] .
After the optimized synthesis results are derived, the offline data preparation step is completed. The bioassay is next executed according to the initial synthesis result, and the next step is the online monitoring of droplets.
B. Online Monitoring of Droplets and Resynthesis of the Bioassay
During the execution of the bioassay, the control software must implement the following steps.
Step 1) Error identification: The error identification procedures for the optical detector-based sensing system and CCD camera-based sensing system are different. For the detector-based sensing system, the outputs of each operation are sent to an on-chip detector. After each optical detector operation, the software compares the detection result with a preassigned error threshold. If the optical detection result fails to meet the requirement of the experiment, we conclude that an error has occurred. The detection of the error will trigger the error recovery procedure, i.e., the software will dynamically adjust the synthesis results to reexecute the operation in which an error occurred and bypass the electrodes at which the error occurred. For the CCD camera-based sensing system, the software can carry out a real-time monitoring of all droplets on the biochip. The colors and diameters of the droplets are detected simultaneously by the CCD camera and evaluated for comparisons. Thus, error recovery is triggered as soon as an error occurs. According to the detection results for droplets, both optical detector-based and CCD camera-based systems can locate the on-chip resources with defects. Suppose the output droplet of operation opt o fails to meet the requirement, then we can conclude that the defect may exist in the resources that are assigned to opt o . In order to ensure the reliability of the subsequent operations, this region will be bypassed.
Step 2) Update of sequencing graph: When an error occurs, the control software determines the required recovery operations. According to the above discussion, if an error occurs during a reversible operation, the recovery process is simple. For nonreversible operations, the control software must search the preceding operations until it finds an operation that can provide backup droplets to feed the inputs of the recovery subroutine. As mentioned above, when an error occurs during the implementation of operations, the software will adjust the sequencing of the bioassay according to the category of operation. The pseudocode for the adjustment of the sequencing graph is shown in Algorithm 1. The definition of error recovery graph G Re i for operation opt i can be found in Section III-A. The updates of the sequencing graph for errors that occur during the operations of Categories I, II, and III are shown in Fig. 12 . The categorization of operations can be found in Section III-A. It is important to note that, for some operations, the recovery subroutines may change depending on the error. For example, operation 7 in Fig. 6(a) generates two droplets; one of them is used in the subsequent reaction and the other is stored on chip as the backup droplet. If a single error occurs at operation 14, the biochip will re-execute operations 8-10 and 12.
However, if an error occurs at a predecessor of operation 14, the recovery subroutine for operation 14 will be different. For example, when an error occurs at operation 9, the backup droplet of operation 7 will be used as the input for error recovery. If another error occurs afterward at operation 14, there is no more backup droplet available at the output of operation 7. Thus, the recovery subroutine of operation 14 has to be expanded and it will now include operations 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, and 12. Therefore, the recovery steps are completely different from the case when an error occurs at operation 14.
After the recovery subroutine of an operation is determined, the control software will update the sequencing graph and the corresponding DAG, and then the dynamic resynthesis step will be implemented.
Step 3) Dynamic resynthesis: In the cyberphysical system envisioned here, when an error is detected at a checkpoint, it will trigger the generation of a new mapping of the remaining steps (including proper handling of intermediate results) of the bioassay. This process is referred to here as resynthesis, on the basis of the initial design obtained from the a priori synthesis step. The requirements for the process of resynthesis are as follows.
a) The interruption of other operations should be avoided. Consider the following example. For the bioassay with synthesis results shown in Table I , suppose that an error recovery process is triggered by an error in operation Mix 3 at time instance 10. When the error recovery process is triggered, operation Mix 1 is being implemented. In order to avoid the interruption of Mix 1, in the new synthesis results, the schedule and resource assignment results for Mix 1 should be the same as in the inial synthesis results. b) The electrodes at which an error has been deemed to have occurred should be bypassed in the new synthesis results. c) The completion time of the bioassay should be optimized. To satisfy these requirements, we propose two resynthesis strategies for dynamic resynthesis. The first strategy is based on a local greedy algorithm, and the second is a PRSA-based, global optimization algorithm [3] .
For the greedy algorithm, the first step is to determine all operations that must be adjusted in the resynthesis result. These operations include the operations in the error recovery graph, the erroneous operation, and the set of subsequent operations that will be implemented on electrodes with defects in the initial synthesis result. Other operations will be executed based on the initial synthesis result.
Since the synthesis results for part of the operations are fixed, dynamic resynthesis on the microfluidic array can be modeled as the module placement with an obstacles problem. Here, the operations that are implemented based on the initial synthesis result are fixed a priori as the obstacles, while the other operations that are necessary for recovery are derived through resynthesis and placed in the remaining available chip areas in a greedy fashion. The detailed steps are described as follows.
First, the control software places all operations that need to be rescheduled in a priority queue based on topological sort. These operations include error recovery operations and all successors of the erroneous operation. Then, the software assigns a priority for each operation in the queue. The deepest operation in the subroutine (i.e., the operation at the bottom of the list generated by topological sort) is assigned the lowest priority, while the shallowest (at the top of the list produced by topological sort) operation is assigned the highest priority in the queue.
Next, the control software needs to allocate on-chip resources to these operations. Here, our on-chip resource set R changes with time t. The control software will search for available resources at the current time for the operation with the highest priority. For example, if the operation with the highest priority is a mixing operation, then the system will search for an available m × n cell array that is not occupied from current time t to t+ t. Here, t is the time needed for the operation in the m × n cell array. If suitable idle resources are available, resource binding will be successful and the start time of the operation will be deemed to be the current time. Otherwise, the operation has to be delayed until there are available resources. If multiple resources are available at the same time, the control software will randomly choose one and bind it to the corresponding operation. After resource binding and start or stop time of the operation are determined, the operation will be removed from the priority queue.
Note that the above steps can also be used to generate resynthesis results, when multiple errors are detected at the same time. In this situation, multiple recovery processes are triggered at the same time and the control software generates a priority queue for each recovery process. After these priority queues merged, the control software assigns a priority for each element based on topological sort. Finally, the control software determines new synthesis results for every operation in the merged priority queue.
For a microfluidic biochip with an M × N electrode array, D detectors and P dispensing ports, the computational complexity of searching for available resources (i.e., the maximum empty rectangle) in this resynthesis algorithm is O(MN + D + P). Since we can view the number of detectors and dispensing ports as being constant and we are interested in algorithm scalability for large arrays, the worst-case complexity is O(MN). This is because the software will exhaustively search each electrode/detector/dispensing port in the array and check whether it is available. The computational complexities for other parts of the algorithm are all O(1). Hence, the overall computational complexity of the resynthesis algorithm is O(MN). The pseudocode for the resynthesis procedure is shown in Algorithm 2.
An example of resynthesis is shown in Fig. 13 . Fig. 13 (a) shows the schedule corresponding to the sequencing graphs in Fig. 1(a) . Fig. 13(b) and (c) both show the schedules corresponding to the sequencing graph in Fig. 1(b) . For the sake of clarity, we only show the schedule for mixing operations. Here, Fig. 13(b) is the schedule obtained using the error-recovery algorithm of Fig. 13(b) ; we can see that mixing operation Mix 1 is halted for ten time slots when error recovery operations are executed. The completion time of the bioassay shown in Fig. 13(a) is increased from 18 time slots to 28 time 18 time slots to 28 time slots, which can be unacceptable for many applications. The dynamic scheduling result corresponding to Fig. 1(b) is shown in Fig. 13(c) . When the error is detected at the output of Mix 3 at time 10, the Mix 3 at time 10, the ongoing operation Mix 1 is executed based on the initial synthesis result. We assume that the computing time to generate the new synthesis result is one time slot. In practice, computation time is at least an order of magnitude less than the fluidic operation time. Then at time 11, the control software will generate a new synthesis result based on the updated Fig. 1(b) . As shown in Fig. 13(c) , Mix 1 is completed at time 12 without being interrupted and the experiment is finished at time 18. Thus, the bioassay is executed seamlessly without any time penalty or interruption of other operations.
The resynthesis problem can also be solved using the PRSA-based global optimization method from [3] . The inputs and constraints of the resynthesis problem are different from the initial synthesis problem, as introduced in Section III-A. Suppose that the set of operations for the resynthesis problem is P and the set of constraints is C . We can derive P and C based on P and C introduced in Section IV.
We first define a operator T on the set P. T is a mapping from the set of all operations to the set of operations that have already started at time instant t T (t) :
When an error is detected at time instant t in operation opt i , the set of operations that need to be resynthesized can be written as P = P ∪ R i ∪ O − P(t). Here, R i is the set of recovery operations corresponding to erroneous operation opt i , and O is the set of subsequently operations that will be implemented on electrodes with defects in the initial synthesis result. The method for determining the operations in R i is introduced in Section III-A. Then, according to the module placement information included in the initial synthesis result, and locations of electrodes with defects, operations in O can be determined.
We write the new synthesis results for opt i ∈ P as M opt i . In addition to the set of constraints C, the new synthesis must satisfy the constraint that the region where an error has been deemed to have occurred can no longer be used.
The optimization problem for the resynthesis process can be written as follows:
The above optimization problem can be solved by using the PRSA-based synthesis procedure introduced in [3] . Using this method, we can derive globally-optimized synthesis results with short assay completion time, but the CPU time is high of the order of 20 min for a typical bioassay [13] . Thus, this method is not suitable for online computation of resynthesis results.
V. Simulation Results
In this section, we evaluate the resynthesis approach for error recovery on representative bioassays that are especially prone to fluidic errors. We compare the completion time for the two sensing schemes, and the resynthesis results derived by the greedy algorithm and the PRSA-based global optimization algorithm.
A. Preparation of Plasmid DNA
First, we simulate the preparation of plasmid DNA by alkalinelysis with SDS-minipreparation [31] . The protocols and corresponding sequencing graphs for the preparation of plasmid DNA are described in [17] and [31] . This bioassay is mapped to a 10 × 10 electrode array and all electrodes on the boundary of the array are used as storage cells.
The error-recovery capability of the cyberphysical microfluidic system can be evaluated on the basis of the bioassay completion time when errors are detected. We inject errors randomly into the chip during the execution of the bioassay and compare the completion time of the two sensing schemes. The results are shown in Fig. 14 . Here, the completion time is derived from the greedy algorithm introduced in Section IV, and the results are the average of the values derived from repeating the experiments ten times.
From Fig. 14 , we can see that the completion time for the CCD camera-based sensing scheme is slightly less than the completion time for the optical detector-based scheme. This is because in the CCD camera-based scheme, when an error occurs during an operation, the error recovery procedure is immediately triggered; in the detector-based scheme, the recovery procedure only can be triggered at the end of the erroneous operation. The simulation results for a biochip without the error recovery mechanism are also shown in Fig. 14. For this case (no error recovery), if an error occurs during the bioassay, the final outcome of the entire experiment will be incorrect. As a result, the biochip has to be discarded, and the experiment must be repeated on a new biochip in order to correct the error. If we assume that re-execution of the experiment will be successful, the bioassay completion time will be twice the completion time in the fault-free case. Based on these results, we note that error recovery can reduce the bioassay completion time, and the consumption of biochemical reagents or samples can be reduced.
In reliability-driven error recovery, the electrodes where an error is deemed occurred will not be used in other operations. On the contrary, for the reliability-oblivious error recovery process in [17] , when an error occurs during execution, the region where error occurs will continue to be used in subsequent operations. As discussed in Section III-B, these electrodes with defects may further lead to more errors.
To compare between the completion time for reliabilityoblivious and reliability-driven error recovery procedures, the following simulation was set up. In the reliability-oblivious error recovery, we randomly select one operation opt fe as the first instance of error in the execution of bioassay. The electrodes that are used to implement opt fe are referred to as electrodes with defects. When another operation is implemented again on these electrodes with defects, we assume that there exists a probability P fail that this operation will also fail. For a fixed value of P fail , we simulate reliability-oblivious error recovery 15 times, and determine average completion time. 15 compares the completion time of reliability-driven error recovery and average completion time of reliabilityoblivious error recovery for different values of P fail . Here, the randomly selected opt ef is a mixing operation implemented on a 1 × 4 electrode array. As expected, Fig. 15 shows that the reliability-driven error recovery leads to shorter assay completion time in the presence of defects.
Next, we randomly select another operation as opt fe and run the simulation again. The electrodes that implement opt fe now constitute of a 2 × 4 electrode array. The simulation results are shown in Fig. 16 . We find that as expected, the average completion time for the reliability-oblivious error recovery is higher when more electrodes are likely to be defective. On the other hand, the completion time of reliability-driven error recovery does not depend on the type of defect on the chip and keeps the minimum completion time.
B. Protein Assays: Interpolating Mixing and Exponential Dilution
Next, we evaluate resynthesis and error recovery for two real-life protein assays. These assays lead to the dilution of a protein sample by using two methods, namely, interpolating mixing and exponential dilution. The protocols and corresponding sequencing graphs for these two bioassays are described in [13] . When errors are injected in the sample preparation of interpolating mixing, the completion times of biochips with detector-based and CCD camera-based sensing systems are shown in Fig. 17(a) . The completion time of biochips with detector-based sensing systems and without error recovery mechanism are shown in Fig. 17(b) . The bioassay is mapped to a 10 × 10 electrode array. Fig. 18 reports the completion time when multiple errors are inserted during the interpolating mixing protocol. Note that the completion time defined here only includes time spent on fluid-handling operations, and excludes the CPU time spent on resynthesis. From Fig. 18 , we see that the completion times achieved by the PRSA-based algorithm and greedy algorithm are almost the same, but the CPU times for these two algorithms are different. The experiment was performed on a 2.6-GHz, Intel i5 processor with 6 GB of memory. Both resynthesis algorithms are implemented on the basis of the same initial synthesis result. The CPU time needed was around 33 min for computing the resynthesis results using PRSA, which was ten times more than the bioassay completion time, while the CPU time was less than 5 s for the greedy algorithm, which was only 2.5% of the bioassay completion time. The bioassay completion time derived by greedy algorithm is only slightly higher for the PRSA. Nevertheless, the greedy algorithm is more suitable for online resynthesis because of low CPU time.
While the PRSA-based approach is less attractive for real-time decision making, it provides a useful calibration point for the greedy algorithm and shows that the latter is effective for timely bioassay completion. Moreover, the PRSA-based method can serve as the basis for future error recovery methods based on precomputation and preloading of recovery schedules.
For the exponential dilution protocol introduced in [13] , we evaluate the completion time for the reliability-driven and reliability-oblivious error recovery methods in Fig. 19 . First, we randomly select one operation opt fe as the first instance of error in the execution of bioassay, where opt fe is a dilution operation implemented on a 1×4 electrode subarray. Then for subsequent operations that are implemented on this electrode array with defects, we set P fail as the probability that the operation will fail again. Then corresponding to each value of P fail , we run the simulations 15 times, and derive the average completion time for reliability-oblivious error recovery. In contrast, the defective electrodes are bypassed in reliability-driven error recovery. Thus, the completion time of reliability-driven error recovery is independent of P fail . From the results shown in Fig. 19 , we find that reliability-driven error recovery reduces the bioassay completion time. At the same time, we avoid the problem that any given set of defective electrodes can lead to replicated errors, thus the number of errors in the bioassay is reduced. Hence, less reagents or samples are consumed, leading to lower cost and higher reliability for the experiment.
VI. Conclusion
We showed how recent advances in the integration of optical sensors in a digital microfluidics biochip can be used to make biochips error-resilient. We presented a cyberphysical approach for a physical-aware system reconfiguration that uses sensor data at intermediate checkpoints to dynamically reconfigure the biochip. Real-time experiment monitory techniques based on an integrated optical detector and a CCD camera were considered. Two different sensor-driven resynthesis techniques were developed to recompute electrode-actuation sequences, thereby deriving new schedules, module placements, and droplet routing pathways, with minimum impact on the time-to-response. These two methods were compared in terms of bioassay completion time and CPU time needed for resynthesis. The coordination between the physical-aware control software and the microfluidic biochip allowed sensor data at intermediate checkpoints to be used as feedback to make decisions about completed operations, and dynamically reconfigure the biochip and optimize electrode actuation sequences for subsequent operations. The proposed approach was evaluated and its effectiveness was demonstrated for three representative protein bioassays. For more details about the work presented in this paper, readers are referred to [33] .
